Clicky

News Feeds

HealthFolk's News section is a health news aggregator with a focus on Nigeria, and Africa as a whole.

[Series] Challenges and controversies in childhood tuberculosis

Tags: General

  • 1.

    Global tuberculosis report 2018.

    World Health Organization, Geneva, Switzerland;
  • 2.
    • Jenkins HE
    • Yuen C
    • Rodriguez CR
    • et al.

    Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis.

    Lancet Infect Dis. 17: 285-295
  • 3.
    • Dodd P
    • Yuen C
    • Sismanidis C
    • et al.

    The global burden of tuberculosis mortality in children: a mathematical modelling study.

    Lancet Glob Health. 5: e898-e906
  • 4.

    The burden of multidrug-resistant tuberculosis in children.

    Int J Tuberc Lung Dis. 22: 3-6
  • 5.
    • Jenkins HE
    • Tolman AW
    • Yuen CM
    • et al.

    Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates.

    Lancet. 383: 1572-1579
  • 6.

    United to end tuberculosis: an urgent global response to a global epidemic.

  • 7.

    Universal regimens or universal access to drug susceptibility testing for tuberculosis?.

    Lancet Infect Dis. 19: 224-225
  • 8.

    Strategies to improve tuberculosis case finding in children.

    Public Health Action. 5: 90-91
  • 9.
    • Ramos JM
    • Perez-Butragueno M
    • Tesfamariam A
    • et al.

    Comparing tuberculosis in children aged under 5 versus 5 to 14 years old in a rural hospital in southern Ethiopia: an 18-year retrospective cross-sectional study.

    BMC Public Health. 19: 856
  • 10.

    Childhood tuberculosis: an overview.

    Adv Pediatr. 62: 59-90
  • 11.
    • Oliwa J
    • Karumbi J
    • Marais B
    • et al.

    Tuberculosis as a cause or comorbidity of childhood pneumonia in tuberculosis-endemic areas: a systematic review.

    Lancet Respir Med. 3: 235-243
  • 12.
    • Szkwarko D
    • Hirsch-Moverman Y
    • Du Plessis L
    • et al.

    Child contact management in high tuberculosis burden countries: a mixed-methods systematic review.

    PLoS One. 12e0182185
  • 13.
    • Said K
    • Hella J
    • Ruzegea M
    • et al.

    Immunologic-based diagnosis of latent tuberculosis among children less than 5 years of age exposed and unexposed to tuberculosis in Tanzania: implications for tuberculosis infection screening.

    Pediatr Infect Dis J. 38: 333-339
  • 14.
    • Luzzati R
    • Migliori G
    • Zignol M
    • et al.

    Children under 5 years are at risk for tuberculosis after occasional contact with highly contagious patients: outbreak from a smear-positive healthcare worker.

    Eur Respir J. 50: 11
  • 15.
    • Munthali T
    • Chabala C
    • Chama E
    • et al.

    Tuberculosis caseload in children with severe acute malnutrition related with high hospital-based mortality in Lusaka, Zambia.

    BMC Research Notes. 10: 6
  • 16.
    • Arscott-Mills T
    • Ho-Foster A
    • Lowenstein M
    • et al.

    Yield of screening for TB and HIV among children failing to thrive in Botswana.

    J Trop Pediatr. 60: 27-32
  • 17.
    • Triasih R
    • Robertson CF
    • Duke T
    • Graham SM

    A prospective evaluation of the symptom-based screening approach to the management of children who are contacts of tuberculosis cases.

    Clin Infect Dis. 60: 12
  • 18.
    • Kruk A
    • Gie R
    • Schaaf HS
    • Marais B

    Symptom-based screening of childhood tuberculosis contacts: improved feasibility in resource-limited settings.

    Pediatrics. 121: e1646-e1652
  • 19.
    • Mulenga H
    • Tameris M
    • Luabeya K
    • et al.

    The role of clinical symptoms in the diagnosis of intrathoracic tuberculosis in young children.

    Pediatr Infect Dis J. 34: 1157-1162
  • 20.

    Symptom-based screening of children with household tuberculosis contact.

    Lancet Respir Med. 6: 235-237
  • 21.
    • Martinez L
    • Shen Y
    • Handel A
    • et al.

    Effectiveness of WHO's pragmatic screening algorithm for child contacts of tuberculosis cases in resource-constrained settings: a prospective cohort study in Uganda.

    Lancet Respir Med. 6: 276-286
  • 22.
    • Dodd P
    • Yuen C
    • Becerra M
    • et al.

    Potential effect of household contact management on childhood tuberculosis: a mathematical modelling study.

    Lancet Glob Health. 6: e1329-e1338
  • 23.
    • Detjen A
    • Essajee S
    • Grzemska M
    • Marais B

    Tuberculosis and integrated child health: rediscovering the principles of Alma Alta.

    Int J Infect Dis. 80: S9-S12
  • 24.
    • Breuninger M
    • van Ginneken B
    • Philipsen RHHM
    • et al.

    Diagnostic accuracy of computer-aided detection of pulmonary tuberculosis in chest radiographs: a validation study from sub-Saharan Africa.

    PLoS One. 9e106381
  • 25.
    • Belard S
    • Heuvelings C
    • Banderker E
    • et al.

    Utility of point-of-care ultrasound in children with pulmonary tuberculosis.

    Pediatr Infect Dis J. 37: 637-642
  • 26.
    • Graham S
    • Cuevas L
    • Jean-Philippe P
    • et al.

    Clinical case definitions of intrathoracic tuberculosis in children: an update.

    Clin Infect Dis. 61: S179-S187
  • 27.

    Alternative sputum collection methods for diagnosis of childhood intrathoracic tuberculosis: a systematic literature review.

    Arch Dis Child. 104: 629-635
  • 28.
    • Zar HJ
    • Workman L
    • Isaacs W
    • et al.

    Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens.

    Clin Infect Dis. 55: 1088-1095
  • 29.
    • Walters E
    • van der Zalm M
    • Demers A
    • et al.

    Specimen pooling as a diagnostic strategy for microbiologic confirmation in children with intrathoracic tuberculosis.

    Pediatr Infect Dis J. 38: e128-e131
  • 30.
    • Walters E
    • van der Zalm M
    • Palmer M
    • et al.

    Xpert MTB/RIF on stool is useful for the rapid diagnosis of tuberculosis in young children with severe pulmonary disease.

    Pediatr Infect Dis J. 36: 837-843
  • 31.
    • Walters E
    • Scott L
    • Nabeta P
    • et al.

    Molecular detection of Mycobacterium tuberculosis from stools in young children by use of a novel centrifugation-free processing method.

    J Clin Microbiol. 56: 9
  • 32.
    • Imperiale B
    • Nieves C
    • Mancio B
    • et al.

    String test: a new tool for tuberculosis diagnosis and drug-resistance detection in children.

    Int J Mycobacteriol. 7: 162-166
  • 33.
    • Mesman A
    • Calderon R
    • Soto M
    • et al.

    Mycobacterium tuberculosis detection from oral swabs with Xpert MTB/RIF Ultra: a pilot study.

    BMC Research Notes. 12: 349
  • 34.
    • Zar HJ
    • Hanslo D
    • Apolles P
    • et al.

    Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study.

    Lancet. 365: 130-134
  • 35.
    • Seki M
    • Kim C
    • Hayakawa S
    • Mitarai S

    Recent advances in tuberculosis diagnostics in resource poor settings.

    Eur J Clin Microbiol Infect Dis. 37: 1405-1410
  • 36.
    • Detjen A
    • DiNardo A
    • Leyden J
    • et al.

    Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis.

    Lancet Respir Med. 3: 451-461
  • 37.
    • Sabi I
    • Rachow A
    • Mapamba D
    • et al.

    Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary TB in children: a multi-center comparative accuracy study.

    Front Pediatr. 77: 321-327
  • 38.
    • Nicol M
    • Workman L
    • Prins M
    • et al.

    Accuracy of MTB/RIF Ultra for the diagnosis of pulmonary TB in children.

    Pediatr Infect Dis J. 37: e261-e263
  • 39.
    • McDowell A
    • Raizada N
    • Khaparde SD
    • et al.

    “Before Xpert I only had my expertise”: a qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities.

    PLoS One. 13e0193656
  • 40.
    • Nicol M
    • Allen V
    • Workman L
    • et al.

    Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study.

    Lancet Glob Health. 2: e278-e284
  • 41.
    • LaCourse S
    • Pavlinac P
    • Cranmer L
    • et al.

    Stool Xpert MTB/RIF and urine lipoarabinomannan for the diagnosis of tuberculosis in hospitalized HIV-infected children.

    AIDS. 32: 69-78
  • 42.
    • Broger T
    • Sossen B
    • duToit E
    • et al.

    Novel lipoarabinomanna point of care tuberculosis test for people living with HIV: a diagnostic accuracy study.

    Lancet Infect Dis. 19: 852-861
  • 43.
    • Walzl G
    • McNerney R
    • du Plessis N
    • et al.

    Tuberculosis: advances and challenges in development of new diagnostics and biomarkers.

    Lancet Infect Dis. 18: e199-e210
  • 44.
    • Jenkins HE
    • Yuen C
    • Rodriguez CA
    • et al.

    Mortality among children diagnosed with tuberculosis: systematic review and meta-analysis.

    Lancet Infect Dis. 17: 285-293
  • 45.
    • Wobudeya E
    • Jaganath D
    • Sekadde M
    • et al.

    Outcomes of empiric treatment for pediatric tuberculosis, Kampala, Uganda, 2010–2015.

    BMC Public Health. 19: 446
  • 46.

    Overcoming challenges in the diagnosis, prevention, and treatment of pediatric drug-resistant tuberculosis.

    Expert Rev Respir Med. 11: 385-394
  • 47.

    Programmatic management of children with drug-resistant tuberculosis: common sense and social justice.

    Public Health Action. 5: 92
  • 48.
    • Nguipdop-Djomo P
    • Heldal E
    • Rodrigues LC
    • et al.

    Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study.

    Lancet Infect Dis. 16: 219-226
  • 49.
    • Nemes E
    • Geldenhyus H
    • Rozot V
    • et al.

    Prevention of infection with Mycobacteroum tuberculosis by H4:IC31 or BCG revaccination in adolescents.

    N Engl J Med. ()
  • 50.
    • Van Der Meeren O
    • Hatherhill M
    • Nduba V
    • et al.

    Phase IIB controlled trial of M72/AS01E vaccine to prevent tuberculosis.

    N Engl J Med. 379: 1621-1634
  • 51.
    • Basu-Roy R
    • Whittaker E
    • Seddon J
    • Kampmann B

    Tuberculosis susceptibility and protection in children.

    Lancet Infect Dis. 19: e96-e108
  • 52.
    • Martinez L
    • Lo NC
    • Cords O
    • et al.

    Paediatric tuberculosis transmission outside the household: challenging historical paradigms to inform future public health strategies.

    Lancet Respir Med. 7: 544-552
  • 53.
    • Van Wyk S
    • Mandalakas A
    • Enarson D
    • et al.

    Tuberculosis contact investigation in a high-burden setting: house or household?.

    Int J Tuberc Lung Dis. 16: 157-162
  • 54.
    • Fox GJ
    • Dobler CC
    • Marais BJ
    • Denholm JT

    Preventive therapy for latent tuberculosis infection—the promise and the challenges.

    Int J Infect Dis. 56: 68-76
  • 55.
    • Chiang SS
    • Roche S
    • Contreras C
    • et al.

    Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study.

    Int J Tuberc Lung Dis. 21: 154-160
  • 56.

    Advances in the diagnosis, treatment, and prevention of tuberculosis in children.

    Expert Rev Respir Med. 13: 301-311
  • 57.
    • Yuen CM
    • Amanullah F
    • Dharmadhikari A
    • et al.

    Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment.

    Lancet. 386: 2334-2343
  • 58.
    • Ghazarian L
    • Caillat-Zucman S
    • Houdouin V

    Mucosal-associated invariant T cell interactions with commensal and pathogenic bacteria: potential role in antimicrobial immunity in the child.

    Front Immunol. 81837
  • 59.
    • Seddon J
    • Whittaker E
    • Kampmann B
    • et al.

    The evolving research agenda for pediatric tuberculosis infection.

    Lancet Infect Dis. 9: e322-e329
  • 60.
    • Belgaumkar V
    • Chandanwale A
    • Valci C
    • et al.

    Barriers to screening and isoniazid preventive therapy for child contacts of tuberculosis patients.

    Int J Tuberc Lung Dis. 22: 1179-1187
  • 61.
    • Ansumama R
    • Keitell S
    • Roberts G
    • et al.

    Impact of infectious disease epidemics on tuberculosis diagnostic, management, and prevention services: experiences and lessons from the 2014–2015 Ebola virus disease outbreak in West Africa.

    Int J Infect Dis. 56: 101-104
  • 62.
    • Andrews J
    • Nemes E
    • Tameris M
    • et al.

    Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study.

    Lancet Respir Med. 5: 282-290
  • 63.
    • Velaco-Arnaiz E
    • Soriano-Arandes A
    • Latorre I
    • et al.

    Performance of tuberculin skin tests and interferon-gamma release assays in children younger than 5 years.

    Pediatr Infect Dis J. 37: 1235-1241
  • 64.
    • Sharma SK
    • Vashishtha R
    • Chauhan LS
    • et al.

    Comparison of TST and IGRA in diagnosis of latent tuberculosis infection in a high TB-burden setting.

    PLoS One. 12e0169539
  • 65.
    • Chiapinni E
    • Storelli F
    • Tersigni C
    • et al.

    QuantiFERON-TB Gold In-Tube test performance in a large pediatric population investigated for suspected tuberculosis infection.

    Pediatr Respir Rev. ()
  • 66.
    • Aggerbeck H
    • Ruhwald M
    • Hoff ST
    • et al.

    C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: a phase 3 trial.

    PLoS One. 13e0204554
  • 67.
    • Stein C
    • Zalagwo S
    • Malone L
    • et al.

    Resistance and susceptibility to Mycobacterium tuberculosis infection and disease in tuberculosis households in Kampala, Uganda.

    Am J Epidemiol. 187: 1477-1559
  • 68.
    • Amanullah F
    • Ashfaq M
    • Kowhaja S
    • et al.

    High tuberculosis prevalence in children exposed at home to drug-resistant tuberculosis.

    Int J Tuberc Lung Dis. 18: 520-527
  • 69.
    • Zak D
    • Penn-Nicholson A
    • Scriba T
    • et al.

    A blood RNA signature for tuberculosis disease risk: a prospective cohort study.

    Lancet. 387: 2312-2322
  • 70.
    • Adjobimey M
    • Masserey E
    • Adjonou C
    • et al.

    Implementation of isoniazid preventive therapy in children aged under 5 years exposed to tuberculosis in Benin.

    Int J Tuberc Lung Dis. 20: 1055-1059
  • 71.
    • Yuen C
    • Millones A
    • Contreras C
    • et al.

    Tuberculosis household accompaniment to improve the contact management cascade: a prospective cohort study.

    PLoS One. 14e0217104
  • 72.

    Building a tuberculosis-free world on a foundation of universal health coverage.

    Lancet. 393: 1268-1270
  • 73.
    • Meyer A
    • Babyrie D
    • Armstrong-Hough M
    • et al.

    Text messages sent to household tuberculosis contacts in Kampala, Uganda: process evaluation.

    JMIR Mhealth Uhealth. 6e10239
  • 74.

    Latent tuberculosis infection. Updated and consolidated guidelines for programmatic management.

    World Health Organization, Geneva;
  • 75.
    • Churchyard GJ
    • Swindells S

    Controlling latent TB tuberculosis infection in high-burden countries: a neglected strategy to end TB.

    PLoS Med. 16e1002787
  • 76.
    • United States National Library of Medicine

    Evaluation of the effect of 3HP versus periodic 3HP versus 6H in HIV-positive individuals.

  • 77.
    • Borisov A
    • Bahmra-Morris S
    • Njie G
    • et al.

    Update of recommendations for use of once weekly isonizid and rifapentine regimen to treat latent tuberculosis infection.

    MMWR Morb Mortal Wkly Rep. 67: 723-726
  • 78.
    • Huerga H
    • Sanchez-Padilla E
    • Melikyan N
    • et al.

    High prevalence of infection and low incidence of disease in child contacts of patients with drug-resistant tuberculosis: a prospective cohort study.

    Arch Dis Child. 104: 622-628
  • 79.
    • Moore DJ
    • Gaskell KM
    • Allen R

    Exposed! Management of MDR-TB household contacts in an evidence light era.

    Int J Infect Dis. 80S: S13-S16
  • 80.
    • Gracia-Prats A
    • Draper H
    • Finlayson H
    • et al.

    Clinical and cardiovascular safety of long-term levofloxacin in children treated for multidrug-resistant tuberculosis.

    Clin Infect Dis. 67: 1777-1780
  • 81.

    Systematic review, meta-analysis, and cost-effectiveness of treatment of latent tuberculosis infection to reduce progression to multidrug-resistant tuberculosis.

    Clin Infect Dis. 64: 1670-1677
  • 82.
    • Malik A
    • Fuad J
    • Siddiqui S
    • et al.

    TB preventive therapy for individuals exposed to drug-resistant tuberculosis: feasibility and safety of a community-based delivery of fluoroquinolone-containing preventive regimen.

    Clin Infect Dis. ()
  • 83.
    • Cruz AT
    • Garcia-Prats AJ
    • Furin J
    • Seddon JA

    Treatment of multidrug-resistant tuberculosis infection in children.

    Pediatr Infect Dis J. 37: 1061-1064
  • 84.
    • Rodriguez CA
    • Sasse S
    • Yuengling KA
    • Azzawi S
    • Becerra MC
    • Yuen CM

    A systematic review of national policies for the management of persons exposed to tuberculosis.

    Int J Tuberc Lung Dis. 21: 935-940
  • 85.
    • The Sentinel Project on Pediatric Drug-Resistant Tuberculosis

    How to care for people exposed to drug-resistant tuberculosis: a practical guide.

  • 86.
    • Hasan R
    • Shakoor S
    • Handfeld J
    • Khan M

    Integrating tuberculosis and antimicrobial resistance control programs.

    Bull World Health Organ. 96: 194-200
  • 87.
    • Knight G
    • McQuaid C
    • Dodd P
    • Houben R

    Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling.

    Lancet Infect Dis. ()
  • 88.

    Improving the quality of pediatric care: an operational guide for facility-based audit and review of pediatric mortality.

  • 89.

    Commentary: a targets framework: dismantling the invisibility trap for children with drug-resistant tuberculosis.

    J Public Health Policy. 35: 425-454
  • 90.
    • Snow K
    • Sismanidis C
    • Denholm J
    • et al.

    The incidence of tuberculosis among adolescents and young adults: a global estimate.

    Eur Respir J. 51 ()
  • 91.
    • Yuen CM
    • Rodriguez CA
    • Keshavjee S
    • Becerra MC

    Map the gap: missing children with drug-resistant tuberculosis.

    Public Health Action. 5: 45-58
  • 92.
    • Seddon J
    • Weld E
    • Schaaf HS
    • et al.

    Conducting efficacy trials in children with MDR-TB: what is the rationale and how should they be done?.

    Int J Tuberc Lung Dis. 22: 24-33
  • 93.
    • Harausz EP
    • Garcia-Prats AJ
    • Law S
    • et al.

    Treatment and outcomes in children with multidrug-resistant tuberculosis: a systematic review and individual patient data meta-analysis.

    PLoS Med. 15e1002591
  • 94.
    • Li H
    • Lu J
    • Liu J
    • Zhao Y
    • Ni X
    • Zhao S

    Linezolid is associated with improved early outcomes of childhood tuberculous meningitis.

    Pediatr Infect Dis J. 35: 607-610
  • 95.
    • South African National Department of Health

    Interim clinical guidance for the implementation of injectable-free regimens for rifampicin-resistant tuberculosis in adults, adolescents, and children.

  • 96.
    • Furin J
    • Tommasi M
    • Garcia-Prats AJ

    Drug-resistant tuberculosis: will grand promises fail children and adolescents?.

    Lancet Child Adolesc Health. 2: 237-238
  • 97.
    • The Sentinel Project on Pediatric Drug-Resistant Tuberculosis

    Management of multidrug-resistant tuberculosis in children: a field guide.

  • 98.
    • Harausz EP
    • Garcia-Prats AJ
    • Seddon JA
    • et al.

    New and repurposed drugs for pediatric multidrug-resistant tuberculosis. Practice-based recommendations.

    Am J Respir Crit Care Med. 195: 1300-1310
  • 99.

    WHO consolidated guidelines on drug-resistant tuberculosis treatment.

  • 100.
    • Furin J
    • Mafukidze A
    • Brigden G
    • et al.

    A bitter pill to swallow: the need for better medications for drug-resistant tuberculosis in children.

    Int J Tuberc Lung Dis. 19: 55-60
  • 101.
    • Taneja R
    • Garcia-Prats AJ
    • Furin J
    • Maheshwari HK

    Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerations.

    Int J Tuberc Lung Dis. 19: 61-68
  • 102.
    • Global Alliance for TB Drug Development

    Child-friendly medicines.

  • 103.

    Tuberculosis.

    Lancet. 393: 1642-1656
  • 104.
    • Nachman S
    • Ahmed A
    • Amanullah F
    • et al.

    Towards early inclusion of children in tuberculosis drugs trials: a consensus statement.

    Lancet Infect Dis. 15: 711-720
  • 105.

    HIV, TB, HCV Pipeline Report.

  • 106.
    • Hoddinott G
    • Staples S
    • Brown R
    • et al.

    Community engagement for paediatric MDR-TB clinical trials: principles to support ethical trial implementation.

    Int J Tuberc Lung Dis. 22: 40-45
  • 107.
    • Van Custem G
    • Isaakidis P
    • Farley J
    • et al.

    infection control for drug-resistant tuberculosis: early diagnosis and treatment is the key.

    Clin Infect Dis. 62: S238-S243
  • 108.
    • Bassili A
    • Fitzpatrick C
    • Qadeer E
    • Fatima R
    • Floyd K
    • Jaramillo E

    A systematic review of the effectiveness of hospital- and ambulatory-based management of multidrug-resistant tuberculosis.

    Am J Trop Med Hyg. 89: 271-280
  • 109.
    • Weiss P
    • Chen W
    • Cook VJ
    • Johnston JC

    Treatment outcomes from community-based drug resistant tuberculosis treatment programs: a systematic review and meta-analysis.

    BMC Infectious Disease. 14: 333
  • 110.
    • Thomas BE
    • Shanmugam P
    • Malaisamy M
    • et al.

    Psycho-socio-economic issues challenging multidrug resistant tuberculosis patients: a systematic review.

    PLoS One. 11e0147397
  • 111.
    • Zawedde-Muyanja S
    • Nakanwagi A
    • Dongo JP
    • et al.

    Decentralisation of child tuberculosis services increases case finding and uptake of preventive therapy in Uganda.

    Int J Tuberc Lung Dis. 22: 1314-1321
  • 112.
    • Franck C
    • Seddon JA
    • Hesseling AC
    • et al.

    Assessing the impact of multidrug-resistant tuberculosis in children: an exploratory qualitative study.

    BMC Infect Dis. 14: 1471-1484
  • 113.
    • Guix-Cornellis E
    • Rozas-Quesada L
    • Velasco-Arniaz E
    • et al.

    Impact of nursing interventions on adherence to treatment with antituberculosis drugs in children and young people: a nonrandomized controlled trial.

    J Adv Nurs. ()
  • 114.
    • Weaver M
    • Lonnroth K
    • Howard S
    • et al.

    Interventions to improve adherence to treatment for paediatric tuberculosis in low- and middle-income countries: a systematic review and meta-analysis.

    Bull World Health Organ. 93: 700-711
  • 115.
    • Kanters S
    • Park J
    • Chan K
    • et al.

    Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis.

    Lancet HIV. 4: e31-e40
  • 116.
    • Rachlis B
    • Naanyu V
    • Wachira J
    • et al.

    Community perceptions of community health workers (CHWs) and their roles in management for HIV, tuberculosis and hypertension in western Kenya.

    PLoS One. 11e0149412
  • 117.
    • Ayles H
    • Muyoyeta M
    • Du Toit E
    • et al.

    Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community randomized trial.

    Lancet. 382: 1183-1194
  • 118.
    • Sandgren A
    • Cuevas LE
    • Dara M
    • et al.

    Childhood tuberculosis: progress requires an advocacy strategy now.

    Eur Respir J. 40: 294-297
  • Read more at the original link...

    0 comments
    Report            

    Read On:

    Are you a doctor? Click here and signup to join medical discussion forums, and receive medical job alerts! Free!

    Medical Jobs

    Tags

      
      
     

    Most Recent

    Doctor? Click here to signup to receive news & research in your specialty